ZURICH, Dec 19 (Reuters) - Roche is touting prospective new drugs from its long-underperforming Swiss-led research unit after years of leaning on its California-based Genentech arm to restock its medicine cabinet.

by support@endlesssupplies.biz via Endless Supplies .Biz - News
No comments:
Post a Comment